Skip to main content
PMC home page
Gut logoLink to Gut
. 1986 Sep;27(9):1073–1090. doi: 10.1136/gut.27.9.1073

Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

J E Compston
PMCID: PMC1433796  PMID: 3530896

Full text

PDF
1073

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHRENS E. H., Jr, PAYNE M. A., KUNKEL H. G., EISENMENGER W. J., BLONDHEIM S. H. Primary biliary cirrhosis. Medicine (Baltimore) 1950 Dec;29(4):299–364. doi: 10.1097/00005792-195012000-00002. [DOI] [PubMed] [Google Scholar]
  2. Ajdukiewicz A. B., Agnew J. E., Byers P. D., Wills M. R., Sherlock S. The relief of bone pain in primary biliary cirrhosis with calcium infusions. Gut. 1974 Oct;15(10):788–793. doi: 10.1136/gut.15.10.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aloia J. F., Cohn S. H., Ostuni J. A., Cane R., Ellis K. Prevention of involutional bone loss by exercise. Ann Intern Med. 1978 Sep;89(3):356–358. doi: 10.7326/0003-4819-89-3-356. [DOI] [PubMed] [Google Scholar]
  4. Avioli L. V., Lee S. W., McDonald J. E., Lund J., DeLuca H. F. Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine. J Clin Invest. 1967 Jun;46(6):983–992. doi: 10.1172/JCI105605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BALABANSKI L., HADZHIDEKOV G. MODIFICATIONS OSSEUSES DANS LA CIRRHOSE DU FOIE. Rev Int Hepatol. 1964;14:81–91. [PubMed] [Google Scholar]
  6. Barragry J. M., Corless D., Auton J., Carter N. D., Long R. G., Maxwell J. D., Switala S. Plasma vitamin D-binding globulin in vitamin D deficiency, pregnancy and chronic liver disease. Clin Chim Acta. 1978 Aug 1;87(3):359–365. doi: 10.1016/0009-8981(78)90179-1. [DOI] [PubMed] [Google Scholar]
  7. Barragry J. M., Long R. G., France M. W., Wills M. R., Boucher B. J., Sherlock S. Intestinal absorption of cholecalciferol in alcoholic liver disease and primary biliary cirrhosis. Gut. 1979 Jul;20(7):559–564. doi: 10.1136/gut.20.7.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bengoa J. M., Sitrin M. D., Meredith S., Kelly S. E., Shah N., Baker A. L., Rosenberg I. H. Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology. 1984 Mar-Apr;4(2):261–265. doi: 10.1002/hep.1840040215. [DOI] [PubMed] [Google Scholar]
  9. Chalmers J., Conacher W. D., Gardner D. L., Scott P. J. Osteomalacia--a common disease in elderly women. J Bone Joint Surg Br. 1967 Aug;49(3):403–423. [PubMed] [Google Scholar]
  10. Cohn S. H., Dombrowski C. S. Measurement of total-body calcium, sodium, chlorine, nitrogen, and phosphorus in man by in vivo neutron activation analysis. J Nucl Med. 1971 Jul;12(7):499–505. [PubMed] [Google Scholar]
  11. Collesson L., Grilliat J. P., Mathieu J., Laurent J. L'ostéose raréfiante dans les cirrhoses du foie. Presse Med. 1965 Oct 27;73(45):2571–2574. [PubMed] [Google Scholar]
  12. Compston J. E., Crowe J. P., Horton L. W. Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1-alpha-hydroxy vitamin D3. Br Med J. 1979 Aug 4;2(6185):309–309. doi: 10.1136/bmj.2.6185.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Compston J. E., Crowe J. P., Wells I. P., Horton L. W., Hirst D., Merrett A. L., Woodhead J. S., Williams R. Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease. Dig Dis Sci. 1980 Jan;25(1):28–32. doi: 10.1007/BF01312729. [DOI] [PubMed] [Google Scholar]
  14. Compston J. E., Horton L. W., Laker M. F., Ayers A. B., Woodhead J. S., Bull H. J., Gazet J. C., Pilkington T. R. Bone disease after jejuno-ileal bypass for obesity. Lancet. 1978 Jul 1;2(8079):1–4. doi: 10.1016/s0140-6736(78)91318-1. [DOI] [PubMed] [Google Scholar]
  15. Compston J. E., Horton L. W. Oral 25-hydroxyvitain D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy. Gastroenterology. 1978 May;74(5 Pt 1):900–902. [PubMed] [Google Scholar]
  16. Compston J. E., Horton L. W., Thompson R. P. Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3. Gut. 1979 Feb;20(2):133–136. doi: 10.1136/gut.20.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Compston J. E., Thompson R. P. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet. 1977 Apr 2;1(8014):721–724. doi: 10.1016/s0140-6736(77)92167-5. [DOI] [PubMed] [Google Scholar]
  18. Compston J. E., Vedi S., Webb A. Relationship between toluidine blue-stained calcification fronts and tetracycline-labeled surfaces in normal human iliac crest biopsies. Calcif Tissue Int. 1985 Jan;37(1):32–35. doi: 10.1007/BF02557675. [DOI] [PubMed] [Google Scholar]
  19. Cuthbert J. A., Pak C. Y., Zerwekh J. E., Glass K. D., Combes B. Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology. 1984 Jan-Feb;4(1):1–8. doi: 10.1002/hep.1840040101. [DOI] [PubMed] [Google Scholar]
  20. DUTHIE R. B. A simple method for cutting sections from undecalcified bone for subsequent autoradiography and microscopy. J Pathol Bacteriol. 1954 Jul;68(1):296–297. doi: 10.1002/path.1700680142. [DOI] [PubMed] [Google Scholar]
  21. Daiger S. P., Schanfield M. S., Cavalli-Sforza L. L. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2076–2080. doi: 10.1073/pnas.72.6.2076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Dalén N., Lamke B. Bone mineral losses in alcoholics. Acta Orthop Scand. 1976 Aug;47(4):469–471. doi: 10.3109/17453677608988722. [DOI] [PubMed] [Google Scholar]
  23. Daum F., Rosen J. F., Roginsky M., Cohen M. I., Finberg L. 25-Hydroxycholecalciferol inthe management of rickets associated with extrahepatic biliary atresia. J Pediatr. 1976 Jun;88(6):1041–1043. doi: 10.1016/s0022-3476(76)81073-6. [DOI] [PubMed] [Google Scholar]
  24. Davies M., Mawer E. B., Klass H. J., Lumb G. A., Berry J. L., Warnes T. W. Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3. Dig Dis Sci. 1983 Feb;28(2):145–153. doi: 10.1007/BF01315144. [DOI] [PubMed] [Google Scholar]
  25. Dibble J. B., Sheridan P., Hampshire R., Hardy G. J., Losowsky M. S. Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease. Clin Endocrinol (Oxf) 1981 Oct;15(4):373–383. doi: 10.1111/j.1365-2265.1981.tb00677.x. [DOI] [PubMed] [Google Scholar]
  26. Dibble J. B., Sheridan P., Hampshire R., Hardy G. J., Losowsky M. S. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease. Q J Med. 1982;51(201):89–103. [PubMed] [Google Scholar]
  27. Dibble J. B., Sheridan P., Losowsky M. S. A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q J Med. 1984 Winter;53(209):119–134. [PubMed] [Google Scholar]
  28. Doyle F. H., Gutteridge D. H., Joplin G. F., Fraser R. An assessment of radiological criteria used in the study of spinal osteoporosis. Br J Radiol. 1967 Apr;40(472):241–250. doi: 10.1259/0007-1285-40-472-241. [DOI] [PubMed] [Google Scholar]
  29. Epstein O., Kato Y., Dick R., Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis. Am J Clin Nutr. 1982 Sep;36(3):426–430. doi: 10.1093/ajcn/36.3.426. [DOI] [PubMed] [Google Scholar]
  30. Eriksen E. F., Mosekilde L., Melsen F. Trabecular bone resorption depth decreases with age: differences between normal males and females. Bone. 1985;6(3):141–146. doi: 10.1016/8756-3282(85)90046-8. [DOI] [PubMed] [Google Scholar]
  31. Farrington K., Epstein O., Varghese Z., Newman S. P., Moorhead J. F., Sherlock S. Effect of oral 1,25 dihydroxycholecalciferol on calcium and phosphate malabsorption in primary biliary cirrhosis. Gut. 1979 Jul;20(7):616–619. doi: 10.1136/gut.20.7.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Fraser D. R., Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970 Nov 21;228(5273):764–766. doi: 10.1038/228764a0. [DOI] [PubMed] [Google Scholar]
  33. Frost H. M. Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res. 1969;3(3):211–237. doi: 10.1007/BF02058664. [DOI] [PubMed] [Google Scholar]
  34. Genant H. K., Cann C. E., Ettinger B., Gordan G. S. Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med. 1982 Nov;97(5):699–705. doi: 10.7326/0003-4819-97-5-699. [DOI] [PubMed] [Google Scholar]
  35. Haddad J. G., Jr, Hahn T. J. Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature. 1973 Aug 24;244(5417):515–517. doi: 10.1038/244515a0. [DOI] [PubMed] [Google Scholar]
  36. Haddad J. G., Jr, Walgate J. Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis. J Clin Invest. 1976 Nov;58(5):1217–1222. doi: 10.1172/JCI108575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Heaton K. W., Lever J. V., Barnard D. Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea. Gastroenterology. 1972 Apr;62(4):642–646. [PubMed] [Google Scholar]
  38. Hepner G. W., Roginsky M., Moo H. F. Abnormal vitamin D metabolism in patients with cirrhosis. Am J Dig Dis. 1976 Jul;21(7):527–532. doi: 10.1007/BF01464758. [DOI] [PubMed] [Google Scholar]
  39. Herlong H. F., Recker R. R., Maddrey W. C. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Gastroenterology. 1982 Jul;83(1 Pt 1):103–108. [PubMed] [Google Scholar]
  40. Heubi J. E., Tsang R. C., Steichen J. J., Chan G. M., Chen I. W., DeLuca H. F. 1,25-Dihydroxyvitamin D3 in childhood hepatic osteodystrophy. J Pediatr. 1979 Jun;94(6):977–982. doi: 10.1016/s0022-3476(79)80243-7. [DOI] [PubMed] [Google Scholar]
  41. Imawari M., Akanuma Y., Itakura H., Muto Y., Kosaka K., Goodman D. S. The effects of diseases of the liver on serum 25-hydroxyvitamin D and on the serum binding protein for vitamin D and its metabolites. J Lab Clin Med. 1979 Jan;93(1):171–180. [PubMed] [Google Scholar]
  42. James O., Macklon A. F., Watson A. J. Primary biliary cirrhosis--a revised clinical spectrum. Lancet. 1981 Jun 13;1(8233):1278–1281. doi: 10.1016/s0140-6736(81)92457-0. [DOI] [PubMed] [Google Scholar]
  43. Jung R. T., Davie M., Hunter J. O., Chalmers T. M., Lawson D. E. Abnormal vitamin D metabolism in cirrhosis. Gut. 1978 Apr;19(4):290–293. doi: 10.1136/gut.19.4.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Kaplan M. M., Goldberg M. J., Matloff D. S., Neer R. M., Goodman D. B. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis. Gastroenterology. 1981 Oct;81(4):681–685. [PubMed] [Google Scholar]
  45. Kato Y., Epstein O., Dick R., Sherlock S. Radiological patterns of cortical bone modelling in women with chronic liver disease. Clin Radiol. 1982 May 3;33(3):313–317. doi: 10.1016/s0009-9260(82)80276-6. [DOI] [PubMed] [Google Scholar]
  46. Kehayoglou A. K., Holdsworth C. D., Agnew J. E., Whelton M. J., Sherlock S. Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Lancet. 1968 Apr 6;1(7545):715–718. doi: 10.1016/s0140-6736(68)92164-8. [DOI] [PubMed] [Google Scholar]
  47. Kobayashi A., Kawai S., Ohkubo M., Ohbe Y. Serum 25-hydroxy-vitamin D in hepatobiliary disease in infancy. Arch Dis Child. 1979 May;54(5):367–370. doi: 10.1136/adc.54.5.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Kobayashi A., Kawai S., Utsunomiya T., Obe Y. Bone disease in infants and children with hepatobiliary disease. Arch Dis Child. 1974 Aug;49(8):641–646. doi: 10.1136/adc.49.8.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Kooh S. W., Jones G., Reilly B. J., Fraser D. Pathogenesis of rickets in chronic hepatobiliary disease in children. J Pediatr. 1979 Jun;94(6):870–874. doi: 10.1016/s0022-3476(79)80204-8. [DOI] [PubMed] [Google Scholar]
  50. Krawitt E. L. Effect of ethanol ingestion on duodenal calcium transport. J Lab Clin Med. 1975 Apr;85(4):665–671. [PubMed] [Google Scholar]
  51. Krawitt E. L., Grundman M. J., Mawer E. B. Absorption, hydroxylation, and excretion of vitamin D3 in primary biliary cirrhosis. Lancet. 1977 Dec 17;2(8051):1246–1249. doi: 10.1016/s0140-6736(77)92660-5. [DOI] [PubMed] [Google Scholar]
  52. Kristensson H., Lundén A., Nilsson B. E. Fracture incidence and diagnostic roentgen in alcoholics. Acta Orthop Scand. 1980 Apr;51(2):205–207. doi: 10.3109/17453678008990787. [DOI] [PubMed] [Google Scholar]
  53. LICHTWITZ A., CACHIN M., HIOCO D., TUTIN M., de SEZE [The phosphocalcium syndrome of cirrhosis]. Sem Hop. 1959 Aug 18;35:2399–2409. [PubMed] [Google Scholar]
  54. Long R. G., Barragry J. M., Mitchenere P., Beer M. S., Boucher B. J., Cohen R. D. Effect of conjugated and unconjugated hyperbilirubinaemia on the plasma 25-hydroxy-vitamin D response to ultraviolet radiation in the rat. Clin Sci (Lond) 1980 Oct;59(4):293–296. doi: 10.1042/cs0590293. [DOI] [PubMed] [Google Scholar]
  55. Long R. G., Meinhard E., Skinner R. K., Varghese Z., Wills M. R., Sherlock S. Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut. 1978 Feb;19(2):85–90. doi: 10.1136/gut.19.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Long R. G., Skinner R. K., Wills M. R., Sherlock S. Formation of vitamin D metabolites from 3H- and 14C-radiolabelled vitamin D-3 in chronic liver diseases. Clin Chim Acta. 1978 May 2;85(3):311–317. doi: 10.1016/0009-8981(78)90309-1. [DOI] [PubMed] [Google Scholar]
  57. Long R. G., Skinner R. K., Wills M. R., Sherlock S. Serum-25-hydroxy-vitamin-D in untreated parenchymal and cholestatic liver disease. Lancet. 1976 Sep 25;2(7987):650–652. doi: 10.1016/s0140-6736(76)92463-6. [DOI] [PubMed] [Google Scholar]
  58. Long R. G., Varghese Z., Meinhard E. A., Skinner R. K., Wills M. R., Sherlock S. Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia. Br Med J. 1978 Jan 14;1(6105):75–77. doi: 10.1136/bmj.1.6105.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Long R. G., Varghese Z., Skinner R. K., Wills M. R., Sherlock S. Phosphate metabolism in chronic liver disease. Clin Chim Acta. 1978 Aug 1;87(3):353–358. doi: 10.1016/0009-8981(78)90178-x. [DOI] [PubMed] [Google Scholar]
  60. Lund B., Sorensen O. H., Hilden M., Lund B. The hepatic conversion of vitamin D in alcoholics with varying degrees of liver affection. Acta Med Scand. 1977;202(3):221–224. doi: 10.1111/j.0954-6820.1977.tb16815.x. [DOI] [PubMed] [Google Scholar]
  61. Matloff D. S., Kaplan M. M., Neer R. M., Goldberg M. J., Bitman W., Wolfe H. J. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology. 1982 Jul;83(1 Pt 1):97–102. [PubMed] [Google Scholar]
  62. Mawer E. B., Schaefer K., Lumb G. A., Stanbury S. W. The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition. Clin Sci. 1971 Jan;40(1):39–53. doi: 10.1042/cs0400039. [DOI] [PubMed] [Google Scholar]
  63. Melsen F., Mosekilde L. Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res. 1978 Dec 8;26(2):99–102. doi: 10.1007/BF02013242. [DOI] [PubMed] [Google Scholar]
  64. Meyer M. S., Wexler S., Jedvab M., Spirer Z., Keysar N., Shibolet S. Low levels of serum calcium, phosphorus and plasma 25-hydroxy vitamin D in cirrhosis of the liver. Isr J Med Sci. 1978 Jul;14(7):725–730. [PubMed] [Google Scholar]
  65. Mobarhan S. A., Russell R. M., Recker R. R., Posner D. B., Iber F. L., Miller P. Metabolic bone disease in alcoholic cirrhosis: a comparison of the effect of vitamin D2, 25-hydroxyvitamin D, or supportive treatment. Hepatology. 1984 Mar-Apr;4(2):266–273. doi: 10.1002/hep.1840040216. [DOI] [PubMed] [Google Scholar]
  66. Monnier L. H., Colette C., Ribot C., Mion C., Mirouze J. Evidence for 25-hydroxyvitamin D deficiency as a factor contributing to osteopenia in diabetic patients with idiopathic haemochromatosis. Eur J Clin Invest. 1980 Jun;10(3):183–187. doi: 10.1111/j.1365-2362.1980.tb00018.x. [DOI] [PubMed] [Google Scholar]
  67. Nilsson B. E., Westlin N. E. Changes in bone mass in alcoholics. Clin Orthop Relat Res. 1973 Jan-Feb;(90):229–232. [PubMed] [Google Scholar]
  68. Nordin B. E. Clinical significance and pathogenesis of osteoporosis. Br Med J. 1971 Mar 13;1(5749):571–576. doi: 10.1136/bmj.1.5749.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Paterson C. R., Losowsky M. S. The bones in chronic liver disease. Scand J Gastroenterol. 1967;2(4):293–300. doi: 10.3109/00365526709180085. [DOI] [PubMed] [Google Scholar]
  70. Peach H., Compston J. E., Vedi S., Horton L. W. Value of plasma calcium, phosphate, and alkaline phosphatase measurements in the diagnosis of histological osteomalacia. J Clin Pathol. 1982 Jun;35(6):625–630. doi: 10.1136/jcp.35.6.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Pentikäinen P. J., Pentikäinen L. A., Azarnoff D. L., Dujovne C. A. Plasma levels and excretion of estrogens in urine in chronic lever disease. Gastroenterology. 1975 Jul;69(1):20–27. [PubMed] [Google Scholar]
  72. Ponchon G., Kennan A. L., DeLuca H. F. "Activation" of vitamin D by the liver. J Clin Invest. 1969 Nov;48(11):2032–2037. doi: 10.1172/JCI106168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Posner D. B., Russell R. M., Absood S., Connor T. B., Davis C., Martin L., Williams J. B., Norris A. H., Merchant C. Effective 25-hydroxylation of vitamin D2 in alcoholic cirrhosis. Gastroenterology. 1978 May;74(5 Pt 1):866–870. [PubMed] [Google Scholar]
  74. Preece M. A., TomlinsonS, Ribot C. A., Pietrek J., Korn H. T., Davies D. M., Ford J. A., Dunnigan M. G., O'Riordan J. L. Studies of vitamin D deficiency in man. Q J Med. 1975 Oct;44(176):575–589. [PubMed] [Google Scholar]
  75. Reed J. S., Meredith S. C., Nemchausky B. A., Rosenberg I. H., Boyer J. L. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. Gastroenterology. 1980 Mar;78(3):512–517. [PubMed] [Google Scholar]
  76. Riggs B. L., Wahner H. W., Dunn W. L., Mazess R. B., Offord K. P., Melton L. J., 3rd Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981 Feb;67(2):328–335. doi: 10.1172/JCI110039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Ross P., Wood B. Osteoarthropathy in idiopathic hemochromatosis. Am J Roentgenol Radium Ther Nucl Med. 1970 Jul;109(3):575–580. doi: 10.2214/ajr.109.3.575. [DOI] [PubMed] [Google Scholar]
  78. SAVILLE P. D. CHANGES IN BONE MASS WITH AGE AND ALCOHOLISM. J Bone Joint Surg Am. 1965 Apr;47:492–499. [PubMed] [Google Scholar]
  79. SNAPPER I., SEELY R., FALK S., FEDER I. Osteomalacia in New York. Ann Intern Med. 1954 Nov;41(5):893–909. doi: 10.7326/0003-4819-41-5-893. [DOI] [PubMed] [Google Scholar]
  80. SUMMERSKILL W. H., KELLY P. J. Osteoporosis with fractures in anicteric cirrhosis: observations supplemented by microradiographic evaluation of bone. Proc Staff Meet Mayo Clin. 1963 Apr 24;38:162–174. [PubMed] [Google Scholar]
  81. Seeman E., Melton L. J., 3rd, O'Fallon W. M., Riggs B. L. Risk factors for spinal osteoporosis in men. Am J Med. 1983 Dec;75(6):977–983. doi: 10.1016/0002-9343(83)90878-1. [DOI] [PubMed] [Google Scholar]
  82. Skinner R. K., Sherlock S., Long R. G., Wilis M. R. 25-Hydroxylation of vitamin D in primary biliary cirrhosis. Lancet. 1977 Apr 2;1(8014):720–721. doi: 10.1016/s0140-6736(77)92166-3. [DOI] [PubMed] [Google Scholar]
  83. Sonnenberg A., von Lilienfeld-Toal H., Sonnenberg G. E., Rohner H. G., Strohmeyer G. Serum 25 -- hydroxyvitamin D3 levels in patients with liver disease. Acta Hepatogastroenterol (Stuttg) 1977 Aug;24(4):256–258. [PubMed] [Google Scholar]
  84. Southgate D. A., Widdowson E. M., Smits B. J., Cooke W. T., Walker C. H., Mathers N. P. Absorption and excretion of calcium and fat by young infants. Lancet. 1969 Mar 8;1(7593):487–489. doi: 10.1016/s0140-6736(69)91589-x. [DOI] [PubMed] [Google Scholar]
  85. Stamp T. C. Intestinal absorption of 25-hydroxycholecalciferol. Lancet. 1974 Jul 20;2(7873):121–123. doi: 10.1016/s0140-6736(74)91553-0. [DOI] [PubMed] [Google Scholar]
  86. Stellon A. J., Davies A., Compston J., Williams R. Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy. Gastroenterology. 1985 Nov;89(5):1078–1083. doi: 10.1016/0016-5085(85)90212-4. [DOI] [PubMed] [Google Scholar]
  87. Stellon A. J., Davies A., Compston J., Williams R. Osteoporosis in chronic cholestatic liver disease. Q J Med. 1985 Nov;57(223):783–790. [PubMed] [Google Scholar]
  88. TENG C. T., DAESCHNER C. W., Jr, SINGLETON E. B., ROSENBERG H. S., COLE V. W., HILL L. L., BRENNAN J. C. Liver diseases and osteoporosis in children. I. Clinical observations. J Pediatr. 1961 Nov;59:684–702. doi: 10.1016/s0022-3476(61)80005-x. [DOI] [PubMed] [Google Scholar]
  89. Thompson G. R., Lewis B., Booth C. C. Absorption of vitamin D3-3H in control subjects and patients with intestinal malabsorption. J Clin Invest. 1966 Jan;45(1):94–102. doi: 10.1172/JCI105327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Thompson W. G., Thompson G. R. Effect of cholestyramine on the absorption of vitamin D3 and calcium. Gut. 1969 Sep;10(9):717–722. doi: 10.1136/gut.10.9.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Vedi S., Compston J. E., Webb A., Tighe J. R. Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects. Metab Bone Dis Relat Res. 1982;4(4):231–236. doi: 10.1016/0221-8747(82)90032-7. [DOI] [PubMed] [Google Scholar]
  92. Vedi S., Compston J. E., Webb A., Tighe J. R. Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Relat Res. 1983;5(2):69–74. doi: 10.1016/0221-8747(83)90004-8. [DOI] [PubMed] [Google Scholar]
  93. Verbanck M., Verbanck J., Brauman J., Mullier J. P. Bone histology and 25-OH vitamin D plasma levels in alcoholics without cirrhosis. Calcif Tissue Res. 1977 May;22 (Suppl):538–541. doi: 10.1007/BF02064155. [DOI] [PubMed] [Google Scholar]
  94. Wagonfeld J. B., Nemchausky B. A., Bolt M., Horst J. V., Boyer J. L., Rosenberg I. H. Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis. Lancet. 1976 Aug 21;2(7982):391–394. doi: 10.1016/s0140-6736(76)92407-7. [DOI] [PubMed] [Google Scholar]
  95. Whelton M. J., Kehayoglou A. K., Agnew J. E., Turnberg L. A., Sherlock S. 47 Calcium abosrption in parenchymatous and biliary liver disease. Gut. 1971 Dec;12(12):978–983. doi: 10.1136/gut.12.12.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. de Vernejoul M. C., Bielakoff J., Herve M., Gueris J., Hott M., Modrowski D., Kuntz D., Miravet L., Ryckewaert A. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. Clin Orthop Relat Res. 1983 Oct;(179):107–115. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES